• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[lindenane 倍半萜类化合物及其低聚物的化学和生物活性。]

Chemistry and bioactivity of lindenane sesquiterpenoids and their oligomers.

机构信息

Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.

出版信息

Nat Prod Rep. 2024 Jan 24;41(1):25-58. doi: 10.1039/d3np00022b.

DOI:10.1039/d3np00022b
PMID:37791885
Abstract

Covering: 1925 to July 2023Among the sesquiterpenoids with rich structural diversity and potential bioactivities, lindenane sesquiterpenoids (LSs) possess a characteristic , -3,5,6-carbocyclic skeleton and mainly exist as monomers and diverse oligomers in plants from the genus and Chloranthaceae family. Since the first identification of lindeneol from in 1925, 354 natural LSs and their oligomers with anti-inflammatory, antitumor, and anti-infective activities have been discovered. Structurally, two-thirds of LSs exist as oligomers with interesting skeletons through diverse polymeric patterns, especially Diels-Alder [4 + 2] cycloaddition. Fascinated by their diverse bioactivities and intriguing polycyclic architectures, synthetic chemists have engaged in the total synthesis of natural LSs in recent decades. In this review, the research achievements related to LSs from 1925 to July of 2023 are systematically and comprehensively summarized, focusing on the classification of their structures, chemical synthesis, and bioactivities, which will be helpful for further research on LSs and their oligomers.

摘要

涵盖时间

1925 年至 2023 年 7 月

在具有丰富结构多样性和潜在生物活性的倍半萜类化合物中,[lindenane sesquiterpenoids(LSs)]具有特征性的,-3,5,6-碳环骨架,主要以单体和各种低聚物的形式存在于[木兰属]和金粟兰科植物中。自 1925 年首次从[linden]中鉴定出[lindeneol]以来,已经发现了 354 种具有抗炎、抗肿瘤和抗感染活性的天然 LSs 及其低聚物。在结构上,三分之二的 LSs 以有趣的骨架存在于通过不同聚合模式形成的低聚物中,特别是[Diels-Alder [4 + 2] cycloaddition]。由于其多样的生物活性和引人入胜的多环结构,合成化学家在过去几十年中一直致力于天然 LSs 的全合成。在这篇综述中,系统全面地总结了 1925 年至 2023 年 7 月期间有关 LSs 的研究成果,重点介绍了它们的结构分类、化学合成和生物活性,这将有助于进一步研究 LSs 及其低聚物。

相似文献

1
Chemistry and bioactivity of lindenane sesquiterpenoids and their oligomers.[lindenane 倍半萜类化合物及其低聚物的化学和生物活性。]
Nat Prod Rep. 2024 Jan 24;41(1):25-58. doi: 10.1039/d3np00022b.
2
Terpenoids of plants from Chloranthaceae family: chemistry, bioactivity, and synthesis.植物萜类化合物:化学、生物活性与合成。
Nat Prod Rep. 2024 Sep 18;41(9):1368-1402. doi: 10.1039/d4np00005f.
3
Zigzag-Type Molecular Belts: Synthesis, Structure, and Properties.之字形分子带:合成、结构与性质
Acc Chem Res. 2025 Jul 2. doi: 10.1021/acs.accounts.5c00328.
4
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Short-Term Memory Impairment短期记忆障碍
7
Differently different?: A commentary on the emerging social cognitive neuroscience of female autism.别样不同?:女性自闭症社会认知神经科学的新发展述评。
Biol Sex Differ. 2024 Jun 13;15(1):49. doi: 10.1186/s13293-024-00621-3.
8
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
9
Child, family and professional views on valued communication outcomes for non-verbal children with neurodisability: A qualitative meta-synthesis.儿童、家庭和专业人员对神经发育障碍的非言语儿童有价值的沟通结果的看法:定性元分析。
Int J Lang Commun Disord. 2024 Nov-Dec;59(6):2946-2984. doi: 10.1111/1460-6984.13121. Epub 2024 Oct 17.
10
Updates on Intrinsic Medicinal Chemistry of 1,4-dihydropyridines, Perspectives on Synthesis and Pharmacokinetics of Novel 1,4-dihydropyrimidines as Calcium Channel Blockers: Clinical Pharmacology.1,4 - 二氢吡啶的内在药物化学进展,新型1,4 - 二氢嘧啶作为钙通道阻滞剂的合成与药代动力学展望:临床药理学
Curr Top Med Chem. 2025 Jan 1. doi: 10.2174/0115680266323908241114064318.